IM Cannabis (IMCC) Common Equity (2019 - 2026)

IM Cannabis' Common Equity history runs 8 years deep, the most recent figure standing at -$3.7 million for Q1 2026.

• On a quarterly basis, Common Equity fell 268.97% year-over-year to -$3.7 million in Q1 2026; TTM through Mar 2026 was -$3.7 million, a 268.97% decrease from a year earlier, with the FY2025 full-year figure at -$2.6 million, down 167.69% from the prior year.
• Common Equity declined to -$3.7 million in Q1 2026 per IMCC's latest filing, from -$2.6 million in the prior quarter.
• Across five years, Common Equity topped out at $156.6 million in Q1 2022 and bottomed at -$3.7 million in Q1 2026.
• The 5-year median for Common Equity is $6.2 million (2024), against an average of $25.6 million.
• Across the five-year window, Common Equity rose 1.31% in 2025 and tumbled 268.97% in 2026, its largest moves.
• Year by year, Common Equity stood at $16.7 million in 2022, then sank by 39.7% to $10.1 million in 2023, then plunged by 62.7% to $3.8 million in 2024, then plunged by 169.07% to -$2.6 million in 2025, then sank by 44.14% to -$3.7 million in 2026.
• Per Business Quant, the three latest IMCC Common Equity figures stand at -$3.7 million (Q1 2026), -$2.6 million (Q4 2025), and $3.1 million (Q3 2025).